Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
2.
Indian J Tuberc ; 65(4): 280-284, 2018 Oct.
Article in English | MEDLINE | ID: mdl-30522613

ABSTRACT

BACKGROUND: Tuberculosis (TB) is one of world's oldest infectious disease and ranks alongside HIV as leading infectious killer. Tuberculosis infection control especially in HIV and TB care facilities has warranted attention after the recent health care-associated outbreaks in South Africa. The aim of this study was to describe the tuberculosis infection control measures implemented by HIV and TB care facilities in five high HIV burden provinces in India. METHODS: Baseline assessment of 30 high burden Antiretroviral centers and TB facilities was conducted during Oct 2015-Dec 2015 by AIC trained staff using a structured format. RESULTS: Thirty HIV and TB care facilities in five high HIV burden provinces were enrolled. Facility infrastructure and airborne infection control practices were highly varied between facilities. TB screening and fast tracking at ART centers is happening at majority of centers however inadequate TB infection control training, poor compliance to administrative and personal protective measures and lack of mechanism for health care workers surveillance need attention. CONCLUSIONS: Local specific TB infection control interventions to be designed and implemented at HIV and TB care facilities including implementation of administrative, environmental and use of personal protective equipment's with the training of staff members. Health care workers surveillance needs to be prioritized considering the rising instances of tuberculosis among Health care workers.


Subject(s)
Cross Infection/epidemiology , Disease Outbreaks , HIV Infections/epidemiology , Infection Control , Tuberculosis, Pulmonary/epidemiology , Cross Infection/complications , Cross Infection/prevention & control , HIV Infections/complications , HIV Infections/prevention & control , Health Facilities , Humans , India/epidemiology , Tuberculosis, Pulmonary/complications , Tuberculosis, Pulmonary/prevention & control
3.
Int J Tuberc Lung Dis ; 21(4): 375-380, 2017 04 01.
Article in English | MEDLINE | ID: mdl-28284251

ABSTRACT

SETTING: Of 18 sites that participated in an implementation study of the Xpert® MTB/RIF assay in India, we selected five microscopy centres and two reference laboratories. OBJECTIVE: To obtain unit costs of diagnostic tests for tuberculosis (TB) and drug-resistant TB. DESIGN: Laboratories were purposely selected to capture regional variations and different laboratory types. Both bottom-up and the top-down methods were used to estimate unit costs. RESULTS: At the microscopy centres, mean bottom-up unit costs were respectively US$0.83 (range US$0.60-US$1.10) and US$12.29 (US$11.61-US$12.89) for sputum smear microscopy and Xpert. At the reference laboratories, mean unit costs were US$1.69 for the decontamination procedure, US$9.83 for a solid culture, US$11.06 for a liquid culture, US$29.88 for a drug susceptibility test, and US$18.18 for a line-probe assay. Top-down mean unit cost estimates were higher for all tests, and for sputum smear microscopy and Xpert these increased to respectively US$1.51 and US$13.58. The difference between bottom-up and top-down estimates was greatest for tests performed at the reference laboratories. CONCLUSION: These unit costs for TB diagnostics can be used to estimate resource requirements and cost-effectiveness in India, taking into account geographical location, laboratory type and capacity utilisation.


Subject(s)
Microscopy/methods , Polymerase Chain Reaction/methods , Tuberculosis, Multidrug-Resistant/diagnosis , Tuberculosis/diagnosis , Cost-Benefit Analysis , Costs and Cost Analysis , Diagnostic Tests, Routine/economics , Diagnostic Tests, Routine/methods , Humans , India , Microscopy/economics , Polymerase Chain Reaction/economics , Sputum/microbiology
4.
Indian J Tuberc ; 63(1): 4-7, 2016 01.
Article in English | MEDLINE | ID: mdl-27235937

ABSTRACT

India has been implementing HIV/TB collaborative activities since 2001 with rapid scale-up of infrastructure across the country during past decade in National AIDS Control Programme and Revised National TB Control Programme. India has shown over 50% reduction in new infections and around 35% reduction in AIDS-related deaths, thereby being one of the success stories globally. Substantial progress in the implementation of collaborative TB/HIV activities has occurred in India and it is marching towards target set out in the Global Plan to Stop TB and endorsed by the UN General Assembly to halve HIV associated TB deaths by 2015. While the successful approaches have led to impressive gains in HIV/TB control in India, there are emerging challenges including newer pockets with rising HIV trends in North India, increasing drug resistance, high mortality among co-infected patients, low HIV testing rates among TB patients in northern and eastern states in India, treatment delays and drop-outs, stigma and discrimination, etc. In spite of these difficulties, established HIV/TB coordination mechanisms at different levels, rapid scale-up of facilities with decentralisation of treatment services, regular joint supervision and monitoring, newer initiatives like use of rapid diagnostics for early diagnosis of TB among people living with HIV, TB notification, etc. have led to success in combating the threat of HIV/TB in India. This article highlights the steps taken by India, one of the largest HIV/TB programmes in world, in scaling up of the joint HIV-TB collaborative activities, the achievements so far and discusses the emerging challenges which could provide important lessons for other countries in scaling up their programmes.


Subject(s)
Coinfection , Communicable Disease Control/organization & administration , HIV Infections/epidemiology , Tuberculosis/epidemiology , HIV Infections/diagnosis , HIV Infections/drug therapy , Health Policy , Humans , India/epidemiology , Mass Screening , National Health Programs , Tuberculosis/diagnosis , Tuberculosis/drug therapy
5.
Indian J Tuberc ; 62(4): 200-6, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26970459

ABSTRACT

In 2014, Government of India in collaboration with World Health Organization Country Office for India released the policy document on Standards for tuberculosis (TB) care in India after in-depth deliberation with national and international experts. The standards for TB care represent what is expected for quality TB care from the Indian healthcare system including both public and private systems. The details of each standard have been compiled in this review article. It is envisioned that the standards detailed in the manuscript are adapted by all TB care providers across the country.


Subject(s)
Communicable Disease Control/standards , Health Policy , Health Services Accessibility , Tuberculosis/diagnosis , Tuberculosis/drug therapy , Antitubercular Agents/therapeutic use , Drug Monitoring , Early Diagnosis , Humans , India , Medication Adherence , Public Health , Social Support
6.
Indian J Tuberc ; 62(4): 235-8, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26970466

ABSTRACT

To achieve "Universal access to TB care and treatment for all", Revised National Tuberculosis Control Programme (RNTCP) has taken steps to reach the unreached by synergizing the efforts of all partners and stakeholders. RNTCP is engaging with private sector partners in major cities of India with primary focus on notification through innovative partnership mechanisms. The manuscript details the concept behind the public-private mix for TB Care in RNTCP, its evolution and progress over the decades in India.


Subject(s)
Health Services Accessibility , Public-Private Sector Partnerships , Tuberculosis/drug therapy , Antitubercular Agents/therapeutic use , Communicable Disease Control , Humans , India , Quality Assurance, Health Care , Tuberculosis/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...